Fosun International’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Fosun International’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-23,088	Closed	-$205K	–	332
2019 Q1	$205K	Sell	23,088 -238,692	-91%	-$1.94M	0.01%	290
2018 Q4	$1.98M	Hold	261,780	–	–	0.12%	85
2018 Q3	$5.49M	Sell	261,780 -27,903	-10%	-$665K	0.26%	44
2018 Q2	$8.67M	Sell	289,683 -420,317	-59%	-$11.4M	0.44%	36
2018 Q1	$19.3M	Hold	710,000	–	–	1.21%	28
2017 Q4	$20.4M	Hold	710,000	–	–	1.79%	18
2017 Q3	$17.2M	Buy	710,000 +60,000	+9%	+$1.42M	1.71%	20
2017 Q2	$14.5M	Buy	+650,000	New	+$13.7M	1.79%	17

Other funds holding DOVA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fosun International's DOVA Position: Q2 2019 in Review

Fosun International sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q2 2019, closing a stake of 23,088 shares — an estimated $205K sold.

Fosun International first reported a position in DOVA in Q2 2017 and held it in 8 quarters. The position peaked at $20.4M in Q4 2017. 66 funds tracked by Wall St. Rank hold DOVA as of Q2 2019.

Fosun International reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Fosun International sold 23,088 Dova Pharmaceuticals, Inc. Common Stock shares in Q2 2019, an estimated $205K.
Fosun International first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2017 and held it in 8 quarters.
Fosun International's Dova Pharmaceuticals, Inc. Common Stock position peaked at $20.4M in Q4 2017.
66 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q2 2019.

Based on Fosun International's 13F filing for Q2 2019, filed 12 Aug 2019.